These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3376975)

  • 1. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass.
    Salazar DE; Corcoran GB
    Am J Med; 1988 Jun; 84(6):1053-60. PubMed ID: 3376975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.
    Nelson WK; Formica RN; Cooper DL; Schwartz PE; Rutherford TJ
    J Oncol Pharm Pract; 2012 Sep; 18(3):323-32. PubMed ID: 22331238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic characteristics of the obese overfed rat.
    Corcoran GB; Salazar DE; Sorge CL
    Int J Obes; 1989; 13(1):69-79. PubMed ID: 2703295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modification of diet in renal disease and chronic kidney disease epidemiology collaboration formulas versus measured or estimated creatinine clearance in kidney transplant recipients.
    Chrobak L; Dębska-Ślizień A; Jankowska M; Sledziński Z; Rutkowski B
    Transplant Proc; 2014 Oct; 46(8):2664-7. PubMed ID: 25380890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients].
    Apperloo JJ; Gerlag PG; Beerenhout CH; Vader HL
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1016-23. PubMed ID: 17508688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using estimated creatinine clearance for individualizing drug therapy: a reassessment.
    Smith CL; Hampton EM
    DICP; 1990 Dec; 24(12):1185-90. PubMed ID: 2089830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of excretory renal function and urinary protein excretion by determination of body cell mass using bioimpedance analysis.
    Flury S; Trachsler J; Schwarz A; Ambühl PM
    BMC Nephrol; 2015 Oct; 16():174. PubMed ID: 26508208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit.
    Snider RD; Kruse JA; Bander JJ; Dunn GH
    Pharmacotherapy; 1995; 15(6):747-53. PubMed ID: 8602383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of Urinary Creatinine Excretion and Prediction of Renal Function in Morbidly Obese Patients: New Tools from Body Composition Analysis.
    Donadio C; Moriconi D; Berta R; Anselmino M
    Kidney Blood Press Res; 2017; 42(4):629-640. PubMed ID: 28977791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline disposition in obese rats.
    Shum L; Jusko WJ
    J Pharmacol Exp Ther; 1984 Feb; 228(2):380-6. PubMed ID: 6694116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum creatinine and creatinine clearance to estimate renal function in essential hypertension].
    Jabary NS; Martín D; Muñoz MF; Santos M; Herruzo J; Gordillo R; Bustamante J
    Nefrologia; 2006; 26(1):64-73. PubMed ID: 16649427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of weight loss after bariatric surgery on kidney function in a multiethnic Asian population.
    Ngoh CLY; So JBY; Tiong HY; Shabbir A; Teo BW
    Surg Obes Relat Dis; 2016; 12(3):600-605. PubMed ID: 26522229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting metabolic rate, weight, surface area and body composition in obese women.
    Halliday D; Hesp R; Stalley SF; Warwick P; Altman DG; Garrow JS
    Int J Obes; 1979; 3(1):1-6. PubMed ID: 528117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men.
    Chew-Harris JS; Florkowski CM; George PM; Elmslie JL; Endre ZH
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):39-46. PubMed ID: 23129724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating creatinine clearance in morbidity obese patients.
    Dionne RE; Bauer LA; Gibson GA; Griffen WO; Blouin RA
    Am J Hosp Pharm; 1981 Jun; 38(6):841-4. PubMed ID: 7246555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of creatinine clearance in morbidly obese patients.
    Demirovic JA; Pai AB; Pai MP
    Am J Health Syst Pharm; 2009 Apr; 66(7):642-8. PubMed ID: 19299371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity as a risk factor in drug-induced organ injury. III. Increased liver and kidney injury by furosemide in the obese overfed rat.
    Corcoran GB; Salazar DE; Chan HH
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):12-24. PubMed ID: 2467406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variables affecting creatinine clearance prediction.
    Sawyer WT; Canaday BR; Poe TE; Webb CE; Gal P; Joyner PU; Berry JI
    Am J Hosp Pharm; 1983 Dec; 40(12):2175-80. PubMed ID: 6660232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.